Healthcare resources restrictions and human immunodeficiency virus infection;Recortes sanitarios e infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 141, Issue 3, 2013, Pages 114-115

  Soriano, Vicente ^a   Barreiro, Pablo ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

EID: 84880507751     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2013.01.034     Document Type: Article

References (21)

1. World Health Organization. Progress report 2011: Global HIV/AIDS response. Epidemic update and health sector progress towards universal access: WHO, UNICEF, UNAIDS. Geneva, Switzerland: World Health Organisation; 2011 [consultado 20 Ene 2013]. Disponible en: http://www.who.int/hiv/pub/progress- report2011/en/index.html
2. F. Palella Jr., R.K. Baker, A.C. Moorman, J.S. Chmiel, K.C. Wood, and J.T. Brooks Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 2006 27 34
3. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study AIDS 24 2010 1537 1548
4. M. Ray, R. Logan, J. Sterne, S. Hernández-Díaz, J. Robins, C. Sabin HIV-CAUSAL Collaboration The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals AIDS 24 2010 123 137
5. M. Thompson, J. Aberg, J. Hoy, A. Telenti, C. Benson, and P. Cahn Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel JAMA 308 2012 387 402
6. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 2012 [consultado 15 Ene 2013]. Disponible en: http://aidsinfo.nih.gov/contentfiles/lvguidelines/ AdultandAdolescentGL.pdf
7. European AIDS Clinical Society (EACS). Guidelines version 6.1 (November 2012) [consultado 20 Ene 2013]. Disponible en: www.europeanaidsclinicalsociety. org
8. Panel de expertos de Gesida y Plan Nacional sobre el Sida Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012) Enferm Infecc Microbiol Clin 30 2012 e1 e89
9. T. Gonzalo, M. García, and M.A. Muñoz-Fernández Socio-economic impact of antiretroviral treatment in HIV patients. An economic review of cost savings after introduction of HAART AIDS Rev 11 2009 79 90
10. A. Blasco, J.R. Arribas, V. Boix, B. Clotet, P. Domingo, and J. González Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult HIV-infected patients in 2012 Enferm Infecc Microbiol Clin 30 2012 283 293
11. S. Moreno, M. Ordobás, J.C. Sanz, B. Ramos, J. Astray, and M. Ortiz Prevalence of undiagnosed HIV infection in the general population having blood tests within primary care in Madrid, Spain Sex Transm Infect 88 2012 522 524
12. B. Smith, R. Morgan, G. Beckett, Y. Falck-Ytter, D. Holtzman, and C. Teo Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep 61 2012 1 32
13. Ministerio de Sanidad, Servicios Sociales e Igualdad. Vigilancia epidemiológica del VIH/sida en España. Actualización 30 de junio de 2012 [consultado 20 Ene 2013]. Disponible en: http://www.msssi.gob.es/ ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/InformeVIHsida- Junio2012.pdf
14. C. De Mendoza, C. Garrido, A. Corral, G. Ramírez-Olivencia, I. Jiménez-Nacher, and N. Zahonero Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients AIDS Res Hum Retroviruses 23 2007 879 885
15. I. Jiménez-Nácher, B. García, P. Barreiro, S. Rodriguez-Novoa, J. Morello, and J. González-Lahoz Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements J Antimicrob Chemother 62 2008 816 822
16. J. Castilla, J. del Romero, V. Hernando, B. Marincovich, S. García, and C. Rodríguez Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV J Acquir Immune Defic Syndr 40 2005 96 101
17. P. Barreiro, J. del Romero, M. Leal, V. Hernando, R. Asencio, and C. de Mendoza Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy J Acquir Immune Defic Syndr 43 2006 324 326
18. P. Barreiro, A. Duerr, K. Beckerman, and V. Soriano Reproductive options for HIV-serodiscordant couples AIDS Rev 8 2006 158 170
19. P. Barreiro, J.A. Castilla, P. Labarga, and V. Soriano Is natural conception a valid option for HIV-serodiscordant couples? Hum Reprod 22 2007 2353 2358
20. P. Labarga, E. Martínez, V. Soriano, and P. Barreiro Reproductive advice in HIV-discordant couples Med Clin (Barc) 129 2007 140 148
21. C. De Mendoza, C. Rodriguez, J.M. Eiros, J. Colomina, F. Garcia, and P. Leiva Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1 Clin Infect Dis 41 2005 227 232